Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
International Journal of Molecular Sciences|June 26, 2025
Endocannabinoid Tone and Oxylipins in Rheumatoid Arthritis and Osteoarthritis-A Novel Target for the Treatment of Pain and Inflammation?Jost Klawitter, Andrew D Clauw, Jennifer A Seifert, et al.
Plos Genetics|March 21, 2009
An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African AmericansJames M Kelley, Laura B Hughes, Jeffrey D Faggard, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|November 8, 2023
Muscle Inflammation Susceptibility: A Potential Phenotype for Guiding Precision Rehabilitation After Total Hip Arthroplasty in End-Stage OsteoarthritisS Louis Bridges, Dongmei Sun, Zachary A Graham, et al.
Arthritis Research & Therapy|September 19, 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RAWilliam Rigby, Jane H Buckner, S Louis Bridges, et al.
Frontiers in Immunology|September 28, 2023
Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetesRuchi Yadav, Quan-Zhen Li, Hanwen Huang, et al.
The Journal of Rheumatology|March 17, 2006
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experienceLarry W Moreland, Michael E Weinblatt, Edward C Keystone, et al.
The Journal of Rheumatology|July 5, 2005
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritisMark C Genovese, Joan M Bathon, Roy M Fleischmann, et al.
The Journal of Rheumatology|March 11, 2009
Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB studyRene Westhovens, Joel M Kremer, Larry W Moreland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2009
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitorsRussell D Bradford, April C Pettit, Patty W Wright, et al.
Drugs & Aging|March 16, 2006
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studiesMichael H Schiff, Elaine B Yu, Michael E Weinblatt, et al.
Pageof 26